Open access · CC-BY
via OpenAlex
Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
Young Chul Youn, Sungmin Kang, Jeewon Suh, Young Ho Park, Min Ju Kang, Jung‐Min Pyun, Seong Hye Choi, Jee Hyang Jeong, Kyung Won Park, Ho‐Won Lee, Seong Soo A. An, Jacqueline C. Dominguez, SangYun Kim
Alzheimer s Research & Therapy · 2019 · ▲ 61 citations
Abstract
INTRODUCTION: Oligomeric amyloid-ß is a major toxic species associated with Alzheimer's disease pathogenesis. Methods used to measure oligomeric amyloid-β in the blood have increased in number in recent years. The Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) is a specific method to measure oligomerization tendencies in the blood. The objective of this study was to determine the association between amyloid-ß oligomerization in the plasma and structural changes of the brain. METHODS: We studied 162 subjects composed of 92 community-based normal healthy subjects, 17 with subjective cognitive decline, 14 with mild cognitive impairment and 39 with Alzheimer's disease dementia. All subjects underwent MDS-OAβ and three-dimensional T1 magnetic resonance imaging. To determine the structural changes of the brain that are statistically correlated with MDS-OAβ level, we used voxel-based morphometry with corrections for age and total intracranial volume covariates. RESULTS: We found brain volume reduction in the bilateral temporal, amygdala, parahippocampal and lower parietal lobe and left cingulate and precuneus regions (family-wise error, p < 0.05). Reduction was also found in white matter in proximity to the left temporal and bilateral lower parietal lobes and posterior corpus callosum (family-wise error, p < 0.05). Brain volume increment was not observed in any regions within grey or white matter. DISCUSSION: Findings suggest that substantial correlation exists between amyloid ß oligomerization in the blood and brain volume reduction in the form of Alzheimer's disease despite of uncertainty in the casual relationship.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13195-019-0499-7
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Youn, Y.C., Kang, S., Suh, J., Park, Y.H., Kang, M.J., Pyun, J., Choi, S.H., Jeong, J.H., Park, K.W., Lee, H., An, S.S.A., Dominguez, J.C., & Kim, S. (2019). Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease. <em>Alzheimer s Research & Therapy</em>. https://doi.org/10.1186/s13195-019-0499-7
Vancouver
Youn YC, Kang S, Suh J, Park YH, Kang MJ, Pyun J, et al. Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease. Alzheimer s Research & Therapy. 2019. doi:10.1186/s13195-019-0499-7.
BibTeX
@article{young2019Blooda,
title = {Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease},
author = {Young Chul Youn and Sungmin Kang and Jeewon Suh and Young Ho Park and Min Ju Kang and Jung‐Min Pyun and Seong Hye Choi and Jee Hyang Jeong and Kyung Won Park and Ho‐Won Lee and Seong Soo A. An and Jacqueline C. Dominguez and SangYun Kim},
journal = {Alzheimer s Research & Therapy},
year = {2019},
doi = {10.1186/s13195-019-0499-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurobiology of Aging 2018
Open access · CC-BY
Impairment in complex activities of daily living is related to neurodegeneration in Alzheimer's disease–specific regions
Neurology 2018
Open access · OA
Arterial stiffness and dementia pathology
Nature Aging 2024
Preprint · OA
Partial reprogramming of the mammalian brain
Dementia & Neuropsychologia 2016
Open access · CC-BY
Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?
Stroke 2005
Citation only
Relationship Between Arterial Stiffness and Cognitive Function in Elderly Subjects With Complaints of Memory Loss
JAMA Neurology 2021
Open access · CC-BY